Literature DB >> 31420408

Analysis of Other Confounding Factors Is Mandatory before Considering That Long-Acting Erythropoiesis Stimulating Agents Are Deleterious to Patients on Dialysis.

Guy Rostoker1, Fanny Lepeytre2, Jacques Rottembourg3.   

Abstract

Entities:  

Keywords:  anemia; chronic hemodialysis; erythropoietin; hemodialysis hazards; mortality risk

Mesh：

Substances：

Year:  2019        PMID： 31420408      PMCID： PMC6727272          DOI： 10.1681/ASN.2019050505

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  3 in total

1.  Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis.

Authors:  Yusuke Sakaguchi; Takayuki Hamano; Atsushi Wada; Ikuto Masakane
Journal:  J Am Soc Nephrol       Date:  2019-04-23       Impact factor: 10.121

Review 2.  Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices.

Authors:  Bruce M Robinson; Tadao Akizawa; Kitty J Jager; Peter G Kerr; Rajiv Saran; Ronald L Pisoni
Journal:  Lancet       Date:  2016-05-22       Impact factor: 79.321

3.  High-Performance Membrane Dialyzers and Mortality in Hemodialysis Patients: A 2-Year Cohort Study from the Annual Survey of the Japanese Renal Data Registry.

Authors:  Masanori Abe; Takayuki Hamano; Atsushi Wada; Shigeru Nakai; Ikuto Masakane
Journal:  Am J Nephrol       Date:  2017-07-04       Impact factor: 3.754
  3 in total
  1 in total

1.  Authors' Reply.

Authors:  Yusuke Sakaguchi; Takayuki Hamano; Atsushi Wada; Ikuto Masakane
Journal:  J Am Soc Nephrol       Date:  2019-08-16       Impact factor: 10.121
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.